NasdaqGS:CAIBiotechs
Caris RIT Aims To Expand Trial Access And Deepen Oncology Integration
Caris Life Sciences (NasdaqGS:CAI) is promoting its Right-In-Time clinical trial solution, focused on closing the geographic gap in cancer trial access for community oncology practices across the US.
The RIT model integrates trial matching into Caris' molecular profiling workflow and is designed to rapidly open eligible trials at local sites when a patient is identified.
The initiative targets logistical and systemic barriers that often keep biomarker driven cancer trials concentrated in...